Wednesday, August 11, 2021 11:39:52 AM
Yes , my son is younger and healthy , and our severe patients in CD12 were mostly over 65 , it was disproportional also with placebo I remember.
And they gave them 2 weeks SC treatment only.
I dont know how long my son will need , I expect that his circulation is better , this is why he improved so fast with SC treatment , and for now he has drug also for 2 weeks, but I will keep an eye on it ...
So his doctor came to check him about 10 AM , at this time my son was on 1 liter nasal cannula oxygen with oxygen saturation of 96-97 , He is stopping dexamethasone now , my son is much stronger , so he said , if other 2 doctors will agree he can go home on oxygen , just to come back Tuesday for next leronlimab.
Of course my son want to go home , I am asking for 1-2 more day to observe him , his oxygen was just a day , two ago 72-74 ..
But no one is listening to me now..:((
No one will believe , I cant believe myself how fast things are going.
What a drug is leronlimab.
I really hope that very soon other people may benefit from it as my son did..
GLTA.
And they gave them 2 weeks SC treatment only.
I dont know how long my son will need , I expect that his circulation is better , this is why he improved so fast with SC treatment , and for now he has drug also for 2 weeks, but I will keep an eye on it ...
So his doctor came to check him about 10 AM , at this time my son was on 1 liter nasal cannula oxygen with oxygen saturation of 96-97 , He is stopping dexamethasone now , my son is much stronger , so he said , if other 2 doctors will agree he can go home on oxygen , just to come back Tuesday for next leronlimab.
Of course my son want to go home , I am asking for 1-2 more day to observe him , his oxygen was just a day , two ago 72-74 ..
But no one is listening to me now..:((
No one will believe , I cant believe myself how fast things are going.
What a drug is leronlimab.
I really hope that very soon other people may benefit from it as my son did..
GLTA.
Recent CYDY News
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/30/2026 08:32:50 PM
- CytoDyn Announces First Patient Dosed in Expanded Access Program for Leronlimab in Triple-Negative Breast Cancer • GlobeNewswire Inc. • 04/27/2026 12:30:00 PM
- CytoDyn to Host Investor Webcast • GlobeNewswire Inc. • 04/23/2026 12:30:00 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 04/22/2026 09:21:50 PM
- CytoDyn Presents New Leronlimab Data in Metastatic Colorectal Cancer at AACR Annual Meeting 2026 • GlobeNewswire Inc. • 04/22/2026 12:30:00 PM
- CytoDyn Completes Enrollment in Phase 2 Metastatic Colorectal Cancer Study • GlobeNewswire Inc. • 04/21/2026 08:10:00 PM
- CytoDyn Presents New Leronlimab Data in Metastatic Triple-Negative Breast Cancer at AACR Annual Meeting 2026 • GlobeNewswire Inc. • 04/20/2026 12:30:00 PM
- CytoDyn to Present at the AACR Annual Meeting 2026 • GlobeNewswire Inc. • 04/14/2026 12:30:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 04/08/2026 09:15:18 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 04/08/2026 12:30:28 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/25/2026 09:16:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:24:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:23:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:22:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:21:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:20:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:20:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/24/2026 09:15:24 PM
- CytoDyn Presents at AACR Special Conference in Cancer Research: Brain Cancer • GlobeNewswire Inc. • 03/24/2026 12:30:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/09/2026 09:15:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2026 01:35:02 PM
- CytoDyn Closes $17.5 Million Financing to Fund Continued Development of Leronlimab • GlobeNewswire Inc. • 03/05/2026 01:30:00 PM
- CytoDyn Presents Novel CCR5 Inhibition Mechanisms and Long-Term Survival Signals for Leronlimab in Metastatic Breast Cancer at AACR Immuno-Oncology Conference • GlobeNewswire Inc. • 02/20/2026 01:30:00 PM
